Jean-Francois Morineau
Director de Operaciones en BNP Paribas Real Estate Conseil Habitation & Hospitality SAS .
Perfil
Jean-Francois Morineau has worked as a Director at Egle Therapeutics SAS and as a Chief Operating Officer at BNP Paribas Real Estate Conseil Habitation & Hospitality SAS from 2011 to present.
Cargos activos de Jean-Francois Morineau
Empresas | Cargo | Inicio |
---|---|---|
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS Real Estate DevelopmentFinance Part of BNP Paribas SA, BNP Paribas Real Estate Conseil Habitation & Hospitality SAS operates as a real estate agency. The company is based in Issy-Les-Moulineaux, France. | Director de Operaciones | 11/05/2011 |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS
BNP Paribas Real Estate Conseil Habitation & Hospitality SAS Real Estate DevelopmentFinance Part of BNP Paribas SA, BNP Paribas Real Estate Conseil Habitation & Hospitality SAS operates as a real estate agency. The company is based in Issy-Les-Moulineaux, France. | Finance |
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Commercial Services |
- Bolsa de valores
- Insiders
- Jean-Francois Morineau